Simple Summary Beyond the TNM-staging system, biomarkers are needed to guide cancer
treatments. We provide an overview of the Immunoscore, a standardized immune assay …

The past two decades witnessed the appreciation of the importance of specific tumor-
infiltrating immune cells in influencing tumor evolution. The discovery that a favorable …

Background New and fully validated tests need to be brought into clinical practice to improve
the estimation of recurrence risk in patients with colon cancer. The aim of this study was to …

3500 Background: Mounting evidence indicates an enhanced lymphocytic reaction as an
informative prognostic indicator in colon cancer (CC). The IM methodology has been defined …

Immunoscore® is an in vitro diagnostic assay that is designed to predict the risk of relapse in
patients with early-stage colon cancer, thus helping to guide treatment strategies …

This review details the analytical performance characteristics of the consensus
Immunoscore, measuring the immune response to cancer, improving the estimation of risk of …

Tumors evolve in close interaction with their microenvironment, which encompasses a
continual tension between the developing tumor and the host immune system. Clinical trials …

Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) tumor, nodes, metastasis (TNM) classification system based on tumor features …

In clinical practice, the administration of adjuvant chemotherapy (ACT) following tumor
surgical resection raises a critical dilemma for stage II colon cancer (CC) patients. The …

Simple Summary This work determines the predictive value of the consensus Immunoscore
in 1885 patients with AJCC/UICC-TNM stage I-II Colon Cancer (CC) from North American …